Concord Biotech shares list at 21% premium; surge up to 26% post debut
Post listing, Concord Biotech shares gained 26.2% to hit a high of ₹934.90 on the BSE, while it touched a high of ₹925.90 on the NSE, up 25% against the IPO price.
concord biotech ipo
August 2023
August 2022
SEBI nod to IPO of Mamaearth parent; NSDL's put under ‘abeyance’
The proposed IPO of NSDL has been kept in abeyance in the backdrop of an ongoing probe against NSE, which is the second-largest shareholder in the securities depository firm.
Concord Biotech, two other IPOs to hit D-Street today; ₹1,600 cr at stake
The three-day IPOs of Concord Biotech, Yudiz Solutions, and Sangani Hospitals will close on August 8.
Rakesh Jhunjhunwala-backed Concord Biotech files for IPO
The Ahmedabad-based Active Pharmaceutical Ingredients (API) maker’s IPO is entirely an offer for sale.
